Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.
Press releases published on June 20, 2025

ALL4 Mining Commits to Sustainable Cloud Mining Through Renewable-Powered Data Centers
London, UK, June 20, 2025 (GLOBE NEWSWIRE) -- ALL4 Mining, a rising force in cloud-based cryptocurrency mining, today announced a major sustainability milestone: its transition to renewable-powered data centers. By integrating solar, wind, and …

Lithium Argentina Reports 2025 Annual General Meeting Results
ZUG, Switzerland, June 20, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) is pleased to announce the results from its annual general meeting held on June 19, 2025 (the “Meeting”). The Meeting saw …

INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time
SARASOTA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility focused company, reminds shareholders to vote their shares online ahead of the upcoming annual meeting of …

VERSES® Announces Consolidation of Class A Subordinate Voting Shares
VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSD) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, announces the Company is …

Bitget Launches AVAXUSD and BCHUSD Perpetual Futures
Victoria, Seychelles, June 20th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 platform, has announced the listing of AVAXUSD and BCHUSD perpetual futures contracts, effective June 19, 2025 (UTC+8). These additions further enhance …

Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
CHICAGO and FORT WORTH, Texas, June 20, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult- …

VivoPower Closes First Phase of US$121 Million Private Placement
LONDON, June 20, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR) (“VivoPower” or the “Company”) today announced that it has closed the first phase of the previously announced US$121 million investment round led by His Royal Highness …

ideal-finance.com Partners with International Financial Giants to Build a New Mechanism for Global Asset Cross-Border Circulation
New York, USA, June 20, 2025 (GLOBE NEWSWIRE) -- The leading global digital finance platform ideal-finance.com has announced deep strategic collaborations with several top international banks and multinational financial institutions to jointly promote the …

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
SCOTTSDALE, Ariz., June 20, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and …

Trident Resources Completes $2.25 Million Flow-Through Financing
Vancouver, BC, June 20, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) announces that it has closed a non-brokered private placement financing for total gross proceeds of CAD $2,250,000 (the “ …

ideal-finance.com Achieves Breakthrough in Technical Strength, Establishing a Global Benchmark with Full-Stack Self-Developed Financial System
New York, USA, June 20, 2025 (GLOBE NEWSWIRE) -- In the context of rapid globalization in fintech, ideal-finance.com has once again set a new industry standard by announcing the full launch of its next-generation trading system, developed entirely in-house …

Martini Market Fills Over 40% of Presale Allocation Within 24 Hours of Launch on XRP Ledger
DUBAI, United Arab Emirates, June 20, 2025 (GLOBE NEWSWIRE) -- Martini Market, a decentralized prediction market protocol built on the XRP Ledger (XRPL), has announced that over 40% of its $MRT token presale allocation has been filled within the first 24 …

SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors
– If approved, nirogacestat will be the first and only therapy with marketing authorization in the EU for the treatment of desmoid tumors – – Decision from European Commission expected in the third quarter of 2025 – STAMFORD, Conn., June 20, 2025 (GLOBE …

Corporation de Minéraux Stratégiques du Maroc lance son premier programme de forage sur le projet Timarighine
MONTRÉAL, 20 juin 2025 (GLOBE NEWSWIRE) -- Corporation de Minéraux Stratégiques du Maroc (TSXV : MCC) (« Corporation de minéraux stratégiques du Maroc » ou la « Société ») est heureuse d'annoncer le début de son premier programme de forage sur la propriété …

Bilibili Inc. Announces Results of Annual General Meeting
SHANGHAI, June 20, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that each of the proposed resolutions (the …

Morocco Strategic Minerals Launches Maiden Drill Program on Timarighine Property
MONTRÉAL, June 20, 2025 (GLOBE NEWSWIRE) -- Morocco Strategic Minerals Corporation. (TSXV: MCC) ("Morocco Strategic Minerals" or the "Corporation") is pleased to announce the commencement of its maiden drilling program on the Timarighine property, located …

Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference
REDWOOD CITY, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced one oral and six poster presentations …

BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the …

Telix Precision Medicine Announces AlFluor Radiochemistry Platform
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces it has launched a novel PET1 radiochemistry solution based on 18F-aluminium fluoride (AlF …

Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML
SAN DIEGO and TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …